Lack of effectiveness of tissue plasminogen activator 20 or more days after vitrectomy.
Folk
J C
JC
Hershey
J M
JM
Rivers
M B
MB
D005260:Female; D005337:Fibrin / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control; D012008:Recurrence; D012163:Retinal Detachment / Q000601:surgery*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D014821:Vitrectomy
D005337:Fibrin; D010959:Tissue Plasminogen Activator